A group of protein molecules that are important, among other things, for cell division, metabolism and cell death. These molecules play an important role in the development of cancer and therefore pharma companies develop molecules to inhibit them.
For Example: Lenvatinib is a multikinase, Tyrosine Kinase, inhibitor which has shown mainly antiangiogenic properties in vitro and in vivo, and direct inhibition of tumour growth was also observed in in vitro models.